Related Experiment Video
Updated: Apr 3, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition
Abstract:
Renal cell carcinoma (RCC) is the most common malignant renal tumor and is prone to metastasis. However, the molecular variation and mechanism underlying renal cell carcinoma metastasis remains largely unknown. In our previous study, it was found that MYSM-1 was significantly downregulated in renal cell carcinoma tissues as compared with normal renal tissues without metastasis, using proteomics approach. Therefore, we hypothesized that MYSM-1 may suppress the metastasis of renal cell carcinoma in light of paucity of data regarding MYSM-1 in the cancers. In the present study, to confirm the expression status of MYSM-1 in renal cell carcinoma, immunohistochemistry with renal carcinoma tissue microarray was performed. It was shown that MYSM-1 was remarkably decreased in renal carcinoma tissues compared with paired normal control tissues; and that low expression of MYSM-1 was significantly associated with poor overall prognosis and metastasis. To investigate the biological roles of MYSM-1 in vitro in renal carcinoma cell lines, both knockdown using siRNA and over-expression were carried out. It was found that MYSM-1 could suppress the proliferation, migration, and invasion of renal carcinoma cells. In addition, we found that MYSM-1 could inhibit the epithelial-mesenchymal transition. Together, our results demonstrate that MYSM-1 could suppress the metastasis of renal carcinoma cells may be through inhibiting the epithelial-mesenchymal transition (EMT) process.
Insights
MYSM-1 is downregulated in renal cell carcinoma (RCC) and suppresses its metastasis. Low MYSM-1 expression correlates with poor prognosis, indicating its potential as a therapeutic target for kidney cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Renal cell carcinoma (RCC) is the most common kidney cancer, characterized by high metastatic potential.
- The molecular mechanisms driving RCC metastasis are not fully understood.
- Previous proteomics studies indicated MYSM-1 downregulation in non-metastatic RCC tissues.
Purpose of the Study:
- To investigate the expression status of MYSM-1 in renal cell carcinoma (RCC).
- To determine the correlation between MYSM-1 expression and RCC patient prognosis and metastasis.
- To elucidate the biological role of MYSM-1 in RCC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
Main Methods:
- Immunohistochemistry on renal carcinoma tissue microarrays to assess MYSM-1 expression.
- In vitro studies using renal carcinoma cell lines with MYSM-1 knockdown (siRNA) and overexpression.
- Assessment of cell proliferation, migration, invasion, and EMT markers.
Main Results:
- MYSM-1 expression was significantly decreased in renal carcinoma tissues compared to normal controls.
- Low MYSM-1 expression was strongly associated with poor overall prognosis and increased metastasis.
- MYSM-1 suppressed renal cell carcinoma cell proliferation, migration, and invasion.
- MYSM-1 was found to inhibit the epithelial-mesenchymal transition (EMT) process.
Conclusions:
- MYSM-1 acts as a tumor suppressor in renal cell carcinoma.
- Downregulation of MYSM-1 is linked to aggressive disease and metastasis in RCC.
- MYSM-1 may inhibit RCC metastasis by suppressing EMT, suggesting its potential as a therapeutic target.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
Cytoskeletal Coordination in Cell Migration

